Roche
ROG.SW
#34
Rank
NZ$608.87 B
Marketcap
NZ$765.28
Share price
1.53%
Change (1 day)
42.51%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2024: NZ$19.10

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$19.10. In 2024 the company made an earnings per share (EPS) of NZ$19.10 a decrease over its 2023 EPS that were of NZ$28.44.

EPS history for Roche from 1998 to 2024

Annual EPS

Year EPS Change
2024NZ$19.10-32.84%
2023NZ$28.441.95%
2022NZ$27.90-6.29%
2021NZ$29.77-5.53%
2020NZ$31.5216.56%
2019NZ$27.0430.3%
2018NZ$20.7520.22%
2017NZ$17.26-5.81%
2016NZ$18.324.62%
2015NZ$17.51-5.13%
2014NZ$18.46-25.05%
2013NZ$24.6321.73%
2012NZ$20.243.82%
2011NZ$19.498.16%
2010NZ$18.0223.72%
2009NZ$14.56-12.31%
2008NZ$16.61-0.34%
2007NZ$16.6732.13%
2006NZ$12.6142.56%
2005NZ$8.85-22.7%
2004NZ$11.45132.85%
2003NZ$4.92-147.82%
2002NZ-$10.28-209.09%
2001NZ$9.42-57.03%
2000NZ$21.9353.29%
1999NZ$14.3031.24%
1998NZ$10.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.34-9.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.22-36.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.86-85.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.38-29.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.64 13.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.15-67.79%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.25-51.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61-33.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.97-68.74%๐Ÿ‡ฌ๐Ÿ‡ง UK